- Treatment plan: Ibrutinib is given daily until disease progression or intolerable side effects occur. Fludarabine is given on cycles -2 and -1 only. Pembrolizumab is given every 3 weeks from cycle 1 to 35. Minimal residual disease will be measured at 2 years from cycle 1 to determine the need for long- term treatment with ibrutinib.